Selected research
Industry Research
Mycoplasma Medium Industry Research Report 2026
Market perspective
The global Mycoplasma Medium market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Mycoplasma Medium is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Mycoplasma Medium is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Mycoplasma Medium is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Mycoplasma Medium include Chromagar (Kanto Chemical), Hardy Diagnostics, Thermo Fisher, Beijing SanYao Science & Technology, Beijing Vokai Biotechnology, Dalian Bogelin, Huankai, Shanghai Medium and Qingdao Hopebiol, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Mycoplasma Medium market in terms of revenue (US$ million) and, where applicable, sales volume (L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/L) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Mycoplasma Medium Market by Company
Chromagar (Kanto Chemical)
Hardy Diagnostics
Thermo Fisher
Beijing SanYao Science & Technology
Beijing Vokai Biotechnology
Dalian Bogelin
Huankai
Shanghai Medium
Qingdao Hopebiol
Shandong Tuopu
SHANGHAl HALING BIOLOGICAL TECHNOLOGY
Shanghai Nod Biotech
Shanghai Basal Media
Mycoplasma Medium Segment by Type
Liquid Mycoplasma Culture Medium
Solid Mycoplasma Culture Medium
Mycoplasma Medium Segment by Application
Mycoplasma Amplification
Vaccine Production
Others
Mycoplasma Medium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mycoplasma Medium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mycoplasma Medium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mycoplasma Medium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Mycoplasma Medium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Mycoplasma Medium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Mycoplasma Medium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liquid Mycoplasma Culture Medium
- Solid Mycoplasma Culture Medium
Applications
- Mycoplasma Amplification
- Vaccine Production
- Others
Companies covered
- Chromagar (Kanto Chemical)
- Hardy Diagnostics
- Thermo Fisher
- Beijing SanYao Science & Technology
- Beijing Vokai Biotechnology
- Dalian Bogelin
- Huankai
- Shanghai Medium
- Qingdao Hopebiol
- Shandong Tuopu
- SHANGHAl HALING BIOLOGICAL TECHNOLOGY
- Shanghai Nod Biotech
- Shanghai Basal Media
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Mycoplasma Medium Market Size (2021-2032)
- 2.2.2 Global Mycoplasma Medium Sales (2021-2032)
- 2.2.3 Global Mycoplasma Medium Market Average Price (2021-2032)
- 2.3 Mycoplasma Medium by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Liquid Mycoplasma Culture Medium
- 2.3.3 Solid Mycoplasma Culture Medium
- 2.4 Mycoplasma Medium by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Mycoplasma Amplification
- 2.4.3 Vaccine Production
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Mycoplasma Medium Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Mycoplasma Medium Sales (L) of Manufacturers (2021-2026)
- 3.3 Global Mycoplasma Medium Revenue of Manufacturers (2021-2026)
- 3.4 Global Mycoplasma Medium Average Price by Manufacturers (2021-2026)
- 3.5 Global Mycoplasma Medium Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Mycoplasma Medium, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Mycoplasma Medium, Product Type & Application
- 3.8 Global Manufacturers of Mycoplasma Medium, Established Date
- 3.9 Global Mycoplasma Medium Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Chromagar (Kanto Chemical)
- 4.1.1 Chromagar (Kanto Chemical) Company Information
- 4.1.2 Chromagar (Kanto Chemical) Business Overview
- 4.1.3 Chromagar (Kanto Chemical) Mycoplasma Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Chromagar (Kanto Chemical) Mycoplasma Medium Product Portfolio
- 4.1.5 Chromagar (Kanto Chemical) Recent Developments
- 4.2 Hardy Diagnostics
- 4.2.1 Hardy Diagnostics Company Information
- 4.2.2 Hardy Diagnostics Business Overview
- 4.2.3 Hardy Diagnostics Mycoplasma Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Hardy Diagnostics Mycoplasma Medium Product Portfolio
- 4.2.5 Hardy Diagnostics Recent Developments
- 4.3 Thermo Fisher
- 4.3.1 Thermo Fisher Company Information
- 4.3.2 Thermo Fisher Business Overview
- 4.3.3 Thermo Fisher Mycoplasma Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Thermo Fisher Mycoplasma Medium Product Portfolio
- 4.3.5 Thermo Fisher Recent Developments
- 4.4 Beijing SanYao Science & Technology
- 4.4.1 Beijing SanYao Science & Technology Company Information
- 4.4.2 Beijing SanYao Science & Technology Business Overview
- 4.4.3 Beijing SanYao Science & Technology Mycoplasma Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Beijing SanYao Science & Technology Mycoplasma Medium Product Portfolio
- 4.4.5 Beijing SanYao Science & Technology Recent Developments
- 4.5 Beijing Vokai Biotechnology
- 4.5.1 Beijing Vokai Biotechnology Company Information
- 4.5.2 Beijing Vokai Biotechnology Business Overview
- 4.5.3 Beijing Vokai Biotechnology Mycoplasma Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Beijing Vokai Biotechnology Mycoplasma Medium Product Portfolio
- 4.5.5 Beijing Vokai Biotechnology Recent Developments
- 4.6 Dalian Bogelin
- 4.6.1 Dalian Bogelin Company Information
- 4.6.2 Dalian Bogelin Business Overview
- 4.6.3 Dalian Bogelin Mycoplasma Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Dalian Bogelin Mycoplasma Medium Product Portfolio
- 4.6.5 Dalian Bogelin Recent Developments
- 4.7 Huankai
- 4.7.1 Huankai Company Information
- 4.7.2 Huankai Business Overview
- 4.7.3 Huankai Mycoplasma Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Huankai Mycoplasma Medium Product Portfolio
- 4.7.5 Huankai Recent Developments
- 4.8 Shanghai Medium
- 4.8.1 Shanghai Medium Company Information
- 4.8.2 Shanghai Medium Business Overview
- 4.8.3 Shanghai Medium Mycoplasma Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Shanghai Medium Mycoplasma Medium Product Portfolio
- 4.8.5 Shanghai Medium Recent Developments
- 4.9 Qingdao Hopebiol
- 4.9.1 Qingdao Hopebiol Company Information
- 4.9.2 Qingdao Hopebiol Business Overview
- 4.9.3 Qingdao Hopebiol Mycoplasma Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Qingdao Hopebiol Mycoplasma Medium Product Portfolio
- 4.9.5 Qingdao Hopebiol Recent Developments
- 4.10 Shandong Tuopu
- 4.10.1 Shandong Tuopu Company Information
- 4.10.2 Shandong Tuopu Business Overview
- 4.10.3 Shandong Tuopu Mycoplasma Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Shandong Tuopu Mycoplasma Medium Product Portfolio
- 4.10.5 Shandong Tuopu Recent Developments
- 4.11 SHANGHAl HALING BIOLOGICAL TECHNOLOGY
- 4.11.1 SHANGHAl HALING BIOLOGICAL TECHNOLOGY Company Information
- 4.11.2 SHANGHAl HALING BIOLOGICAL TECHNOLOGY Business Overview
- 4.11.3 SHANGHAl HALING BIOLOGICAL TECHNOLOGY Mycoplasma Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 SHANGHAl HALING BIOLOGICAL TECHNOLOGY Mycoplasma Medium Product Portfolio
- 4.11.5 SHANGHAl HALING BIOLOGICAL TECHNOLOGY Recent Developments
- 4.12 Shanghai Nod Biotech
- 4.12.1 Shanghai Nod Biotech Company Information
- 4.12.2 Shanghai Nod Biotech Business Overview
- 4.12.3 Shanghai Nod Biotech Mycoplasma Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Shanghai Nod Biotech Mycoplasma Medium Product Portfolio
- 4.12.5 Shanghai Nod Biotech Recent Developments
- 4.13 Shanghai Basal Media
- 4.13.1 Shanghai Basal Media Company Information
- 4.13.2 Shanghai Basal Media Business Overview
- 4.13.3 Shanghai Basal Media Mycoplasma Medium Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Shanghai Basal Media Mycoplasma Medium Product Portfolio
- 4.13.5 Shanghai Basal Media Recent Developments
5 Global Mycoplasma Medium Market Scenario by Region
- 5.1 Global Mycoplasma Medium Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Mycoplasma Medium Sales by Region: 2021-2032
- 5.2.1 Global Mycoplasma Medium Sales by Region: 2021-2026
- 5.2.2 Global Mycoplasma Medium Sales by Region: 2027-2032
- 5.3 Global Mycoplasma Medium Revenue by Region: 2021-2032
- 5.3.1 Global Mycoplasma Medium Revenue by Region: 2021-2026
- 5.3.2 Global Mycoplasma Medium Revenue by Region: 2027-2032
- 5.4 North America Mycoplasma Medium Market Facts & Figures by Country
- 5.4.1 North America Mycoplasma Medium Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Mycoplasma Medium Sales by Country (2021-2032)
- 5.4.3 North America Mycoplasma Medium Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Mycoplasma Medium Market Facts & Figures by Country
- 5.5.1 Europe Mycoplasma Medium Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Mycoplasma Medium Sales by Country (2021-2032)
- 5.5.3 Europe Mycoplasma Medium Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Mycoplasma Medium Market Facts & Figures by Country
- 5.6.1 Asia Pacific Mycoplasma Medium Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Mycoplasma Medium Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Mycoplasma Medium Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Mycoplasma Medium Market Facts & Figures by Country
- 5.7.1 South America Mycoplasma Medium Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Mycoplasma Medium Sales by Country (2021-2032)
- 5.7.3 South America Mycoplasma Medium Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Mycoplasma Medium Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Mycoplasma Medium Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Mycoplasma Medium Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Mycoplasma Medium Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Mycoplasma Medium Sales by Type (2021-2032)
- 6.1.1 Global Mycoplasma Medium Sales by Type (2021-2032) & (L)
- 6.1.2 Global Mycoplasma Medium Sales Market Share by Type (2021-2032)
- 6.2 Global Mycoplasma Medium Revenue by Type (2021-2032)
- 6.2.1 Global Mycoplasma Medium Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Mycoplasma Medium Revenue Market Share by Type (2021-2032)
- 6.3 Global Mycoplasma Medium Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Mycoplasma Medium Sales by Application (2021-2032)
- 7.1.1 Global Mycoplasma Medium Sales by Application (2021-2032) & (L)
- 7.1.2 Global Mycoplasma Medium Sales Market Share by Application (2021-2032)
- 7.2 Global Mycoplasma Medium Revenue by Application (2021-2032)
- 7.2.1 Global Mycoplasma Medium Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Mycoplasma Medium Revenue Market Share by Application (2021-2032)
- 7.3 Global Mycoplasma Medium Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Mycoplasma Medium Value Chain Analysis
- 8.1.1 Mycoplasma Medium Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Mycoplasma Medium Production Mode & Process
- 8.2 Mycoplasma Medium Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Mycoplasma Medium Distributors
- 8.2.3 Mycoplasma Medium Customers
9 Global Mycoplasma Medium Analyzing Market Dynamics
- 9.1 Mycoplasma Medium Industry Trends
- 9.2 Mycoplasma Medium Industry Drivers
- 9.3 Mycoplasma Medium Industry Opportunities and Challenges
- 9.4 Mycoplasma Medium Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst